PVpharm is pleased to announce the participation of Jose Alberto Ayala Ortiz, PVpharm CEO, as a speaker in the upcoming the DIA India Annual Meeting 2025, taking place at the NESCO Center in Mumbai on September 19, 2025. This important event brings together professionals from across the globe to discuss the latest developments in pharmacovigilance, regulatory science, and patient safety.
The DIA India Annual Meeting is recognized as a premier platform for discussion and collaboration in the field of drug development and pharmacovigilance. Each year, it brings together regulators, pharmaceutical professionals, academic researchers, and technology providers to address shared challenges and opportunities.
The 2025 edition will place particular emphasis on regulatory harmonization, patient safety, and the role of digital transformation in PV. The session on PV Global Regulatory Intelligence Updates will complement these themes by offering a European perspective with global applicability.
Jose Alberto Ayala Ortiz (PVpharm CEO) will take part in the session “PV Global Regulatory Intelligence Updates”. This session will explore the evolving strategies of the European Medicines Agency (EMA) and their implications for pharmacovigilance worldwide.
Join Us and listen to the presentation in Mumbai
If you are attending the DIA India Annual Meeting 2025, make sure to join us for our session and other sessions:
- Session: EMA Strategies and Future Plans: PRAC Contribution, Master Data Management Plan and EU Network Data Strategy including Signal Management
- September 19, 2025 — 11:30 AM to 1:00 PM
- Speaker: Jose Alberto Ayala Ortiz, PVpharm CEO
- NESCO Center, Mumbai
Let’s come together to explore how regulatory foresight, smart data strategies, and proactive signal detection can elevate pharmacovigilance. We look forward to seeing you there and sparking actionable ideas together!
For more details on the full agenda and speakers, please visit the DIA India Annual Meeting 2025 website.
